
Aquestive Therapeutics AQST
$ 4.15
0.48%
Annual report 2025
added 03-04-2026
Aquestive Therapeutics Long Term Debt Current 2011-2026 | AQST
Annual Long Term Debt Current Aquestive Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 631 K | 510 K | 390 K | 255 K | 899 K | 728 K | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 899 K | 255 K | 569 K |
Long Term Debt Current of other stocks in the Biotechnology industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
ADC Therapeutics SA
ADCT
|
1.1 M | $ 3.78 | - | $ 105 M | ||
|
MorphoSys AG
MOR
|
3.63 M | - | 2.43 % | $ 254 M | ||
|
Akebia Therapeutics
AKBA
|
3.55 M | $ 1.35 | -2.17 % | $ 347 M | ||
|
Aldeyra Therapeutics
ALDX
|
281 K | $ 1.58 | -4.82 % | $ 94.9 M | ||
|
Aligos Therapeutics
ALGS
|
3.58 M | $ 8.36 | 4.89 % | $ 82.6 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
45.5 M | $ 330.71 | 3.72 % | $ 43.3 B | ||
|
Altimmune
ALT
|
256 K | $ 3.47 | 3.89 % | $ 306 M | ||
|
ALX Oncology Holdings
ALXO
|
901 K | $ 1.98 | 0.25 % | $ 106 M | ||
|
Amgen
AMGN
|
135 M | $ 346.45 | -0.43 % | $ 186 B | ||
|
I-Mab
IMAB
|
8.06 M | - | - | $ 866 M | ||
|
Amneal Pharmaceuticals
AMRX
|
6.76 M | $ 12.37 | -0.92 % | $ 3.88 B | ||
|
Anika Therapeutics
ANIK
|
1.6 M | $ 15.0 | 1.32 % | $ 220 M | ||
|
ANI Pharmaceuticals
ANIP
|
1.8 M | $ 76.34 | 2.87 % | $ 1.47 B | ||
|
Annexon
ANNX
|
2.91 M | $ 5.64 | 2.45 % | $ 875 M | ||
|
Aptorum Group Limited
APM
|
433 K | $ 0.92 | -1.11 % | $ 5.02 M | ||
|
Aprea Therapeutics
APRE
|
256 K | $ 0.73 | 2.63 % | $ 4.77 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
4.21 M | $ 8.43 | 4.98 % | $ 231 M | ||
|
Ardelyx
ARDX
|
1.48 M | $ 6.08 | 2.27 % | $ 1.47 B | ||
|
argenx SE
ARGX
|
10.8 M | $ 752.05 | 0.75 % | $ 25 B | ||
|
Acorda Therapeutics
ACOR
|
1.59 M | - | -24.86 % | $ 820 K | ||
|
Arcutis Biotherapeutics
ARQT
|
294 K | $ 23.93 | 1.27 % | $ 3.04 B | ||
|
Arvinas
ARVN
|
1.7 M | $ 11.11 | 2.4 % | $ 788 M | ||
|
Adverum Biotechnologies
ADVM
|
5.67 M | - | - | $ 86.2 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
7.29 M | $ 61.57 | 0.88 % | $ 8.24 B | ||
|
Advaxis
ADXS
|
166 K | - | -9.65 % | $ 45.9 M | ||
|
Applied Molecular Transport
AMTI
|
4.64 M | - | - | $ 10.1 M | ||
|
Assembly Biosciences
ASMB
|
569 K | $ 30.01 | 3.43 % | $ 336 M | ||
|
Aeterna Zentaris
AEZS
|
271 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
181 K | - | -10.17 % | $ 12.2 K | ||
|
AIkido Pharma
AIKI
|
554 K | - | 1.93 % | $ 17.4 M | ||
|
Aeglea BioTherapeutics
AGLE
|
625 K | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.27 M | - | - | $ 26.5 M | ||
|
Akouos
AKUS
|
671 K | - | 0.23 % | $ 488 M | ||
|
Actinium Pharmaceuticals
ATNM
|
711 K | $ 1.14 | 16.28 % | $ 35.6 M | ||
|
Atossa Therapeutics
ATOS
|
18.1 K | $ 5.21 | -2.89 % | $ 44.9 M | ||
|
Atara Biotherapeutics
ATRA
|
1.03 M | $ 5.03 | 0.7 % | $ 63.1 M | ||
|
Allena Pharmaceuticals
ALNA
|
317 K | - | 3.16 % | $ 1.9 M | ||
|
Aurinia Pharmaceuticals
AUPH
|
1.07 M | $ 16.04 | 2.75 % | $ 2.16 B | ||
|
Autolus Therapeutics plc
AUTL
|
4.56 M | $ 1.42 | 0.35 % | $ 378 M | ||
|
Alpine Immune Sciences
ALPN
|
756 K | - | - | $ 2.17 B | ||
|
Aileron Therapeutics
ALRN
|
48 K | - | 10.36 % | $ 9.8 M |